What to do: Do not consume, use, sell, serve, or distribute recalled products
Audience: General public
Recall class: Class 1
Canadian Cheddar Cheese
0 60383 83746 4
Best Before 2023 AU 24
The affected product is being recalled from the marketplace due to possible Listeria contamination.
The recalled product has been sold nationally.
What you should do
If you think you became sick from consuming a recalled product, contact your healthcare provider
Check to see if you have recalled products
Do not consume, serve, use, sell, or distribute recalled products
Recalled products should be thrown out or returned to the location where they were purchased
Food contaminated with Listeria monocytogenes may not look or smell spoiled but can still make you sick. Symptoms can include vomiting, nausea, persistent fever, muscle aches, severe headache and neck stiffness. Pregnant women, the elderly and people with weakened immune systems are particularly at risk. Although infected pregnant women may experience only mild, flu-like symptoms, the infection can lead to premature delivery, infection of the newborn or even stillbirth. In severe cases of illness, people may die.
Washington National Insurance Company, a national provider of supplemental health and life insurance products for middle-income Americans, today announced its new Accident Insurance product. Available for individual and worksite sales, Accident...
Calder Biosciences Inc., a molecular engineering and clinical manufacturing-stage biotechnology company pioneering its 3D-Vaxlockä platform technology to engineer and develop novel protein subunit vaccines, today announced a clinical supply agreement...
New data released today at the American Society of Clinical Oncology (ASCO) Annual Meeting highlighted the application of PathomIQ Inc.'s PATHOMIQ_PRAD AI test to assess the risk for metastasis in non-metastatic castration-resistant prostate cancer...
The global active pharmaceutical ingredients and high potency API industry size stood at USD 233.31 billion in 2021 and is poised to observe a CAGR of 6% from 2022 to 2030, according to the "Active Pharmaceutical Ingredients and High Potency API...
OpenBench, Inc., a pioneer in success-driven small molecule discovery collaborations, today announced the launch of a collaboration with Related Sciences ("RS"), a data science-driven drug discovery studio, to leverage OpenBench's structure-based...
MedVanta, the nation's largest physician-owned and led musculoskeletal management services organization (MSO), today announced the appointment of its first Chief Information Officer, Tony Yi, as well as Christine DeAngelis, Senior Vice President,...